Showing results (71-80 of 201) with videos related to

Sort By:
Pageof 21
Blood|October 1, 2005
The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALLDavid T Teachey, Dana A Obzut, Jonathan Cooperman, et al.
Blood|August 23, 2011
Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modelingDavid M Barrett, Alix E Seif, Carmine Carpenito, et al.
Pediatric Blood & Cancer|April 11, 2026
Preferences of Pediatric Patients and Their Caregivers for Chemotherapy-Induced Nausea and Vomiting Control Endpoints: A Mixed Methods StudyHaley Newman, Tadi Hondonga, Alison Berry, et al.
Journal of Immunological Methods|April 7, 2016
Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapyFang Chen, David T Teachey, Edward Pequignot, et al.
Resuscitation|December 25, 2019
Visual attention patterns of team leaders during delivery room resuscitationDanielle D Weinberg, Haley Newman, Claire E Fishman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2022
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19Caroline Diorio, Rawan Shraim, Regina Myers, et al.
Molecular & Cellular Proteomics : MCP|May 29, 2025
A Method for Comparing Proteins Measured in Serum and Plasma by Olink Proximity Extension AssayRawan Shraim, Caroline Diorio, Scott W Canna, et al.
Bone|May 22, 2021
Off-on-off-on use of imatinib in three children with fibrodysplasia ossificans progressivaFrederick S Kaplan, David T Teachey, Jeffrey R Andolina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2012
Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium studyYael P Mossé, Emily Lipsitz, Elizabeth Fox, et al.
Blood|October 28, 2015
Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trialKaren L Bride, Tiffaney Vincent, Kim Smith-Whitley, et al.
Pageof 21